| Literature DB >> 35202237 |
Xiao-Hui Yin1, Yan-Ming Xu1, Andy T Y Lau1.
Abstract
Since the rise and rapid development of nanoscale science and technology in the late 1980s, nanomaterials have been widely used in many areas including medicine, electronic products, crafts, textiles, and cosmetics, which have provided a lot of convenience to people's life. However, while nanomaterials have been fully utilized, their negative effects, also known as nano pollution, have become increasingly apparent. The adverse effects of nanomaterials on the environment and organisms are mainly based on the unique size and physicochemical properties of nanoparticles (NPs). NPs, as the basic unit of nanomaterials, generally refer to the ultrafine particles whose spatial scale are defined in the range of 1-100 nm. In this review, we mainly introduce the basic status of the types and applications of NPs, airborne NP pollution, and the relationship between airborne NP pollution and human diseases. There are many sources of airborne NP pollutants, including engineered nanoparticles (ENPs) and non-engineered nanoparticles (NENPs). The NENPs can be further divided into those generated from natural activities and those produced by human activities. A growing number of studies have found that exposure to airborne NP pollutants can cause a variety of illnesses, such as respiratory diseases, cardiovascular diseases, and neurological disorders. To deal with the ever increasing numbers and types of NPs being unleashed to the air, we believe that extensive research is needed to provide a comprehensive understanding of NP pollution hazards and their impact mechanisms. Only in this way can we find the best solution and truly protect the safety and quality of life of human beings.Entities:
Keywords: air pollution; cardiovascular diseases; nanoparticle toxicity; nanoparticles; neurological disorders; respiratory diseases
Year: 2022 PMID: 35202237 PMCID: PMC8874650 DOI: 10.3390/toxics10020050
Source DB: PubMed Journal: Toxics ISSN: 2305-6304
Type, shape, size, and main applications of ENPs.
| Type | ENPs | Shape | Size | Applications | Ref. |
|---|---|---|---|---|---|
| Carbon-based NPs | C-dots | Dot | <10 nm | Biological imaging | [ |
| Fullerenes | Spherical | ~1 nm | Antioxidant | [ | |
| [ | |||||
| [ | |||||
| [ | |||||
| [ | |||||
| [ | |||||
| [ | |||||
| [ | |||||
| CNTs | Tubular | Diameter: | Biological imaging | [ | |
| Graphene | Flake | Thickness: | Biological imaging | [ | |
| Metal-based | AuNPs | R, SH, SP, | 2–100 nm | Anticancer | [ |
| AgNPs | B, F, H, O, P, | 20–50 nm | Antimicrobial | [ | |
| Enhancers for radiation | [ | ||||
| CuNPs | CU, R, SP, etc. 1 | <100 nm | Antimicrobial | [ | |
| PtNPs | CU, R, SP, etc. 1 | <100 nm | Antimicrobial | [ | |
| Oxide NPs | TiO2 NPs | CU, R, SP, etc. 1 | 20–100 nm | Cosmetics | [ |
| SiO2 NPs | CU, R, SP, etc. 1 | 20–100 nm | Automotive industry | [ | |
| ZnO NPs | CU, R, SP, etc. 1 | 20–100 nm | Cosmetics | [ | |
| Fe2O3 NPs | CU, R, SP, etc. 1 | 20–100 nm | Diagnosis | [ | |
| Al2O3 NPs | CU, R, SP, etc. 1 | 20–100 nm | Increase the strength and toughness of the material | [ | |
| Organic NPs | Liposomes | Spherical | tens of nanometers | Drug delivery carriers | [ |
| Micelles | Spherical | tens of nanometers | Drug delivery carriers | [ | |
| Polymers | Spherical | tens of nanometers | Drug delivery carriers | [ |
1 B: highly branched; CA: nanocage; CU: nanocube; F: flower-shaped; H: hexagon; O: octagon; P: nanopyramid; R: nanorod; SH: nanoshell; SP: nanosphere; T: triangle.
Figure 1Carbon-based NPs in different dimensions. Zero-dimensional carbon-based NPs: C-dot and fullerene. One-dimensional carbon-based NPs: SWCNT and MWCNT. Two-dimensional carbon-based NPs: graphene. Three-dimensional carbon-based NPs: graphite.
Figure 2A summary of the various forms of metal-based NPs and oxide NPs. Metal-based NPs and oxide NPs have very rich forms. In addition to surface chemistry and optical properties, the morphology of ENPs also has an impact on their function. Therefore, people usually adjust the corresponding reaction conditions in the process of nanomaterials synthesis to produce various forms of ENPs, such as nanosphere, nanoshell, nanorod, triangle, hexagon, octagon, nanopyramid, nanocube, highly branched, nanocage, flower-shaped, etc., so as to meet their actual needs.
Figure 3Structural sketches of liposome, micelle, and organic polymer.
Figure 4A summary of the main sources of airborne NPs. The sources of airborne NPs can be broadly divided into two categories: ENPs and NENPs. ENPs are made by artificially controlled engineering processes (i.e., laboratory development, industrial production, product installation and use, product disposal, and recycling). NENPs are the by-products of some natural activities (i.e., dust storms, volcanic eruptions, and forest fires) or human activities (i.e., industrial emissions, transportation emissions, waste incineration, smoking, and human routine activities).
Studies on diseases caused by NPs.
| Diseases | NPs | Size | System | Main Findings | Ref. |
|---|---|---|---|---|---|
| Inflammation | MWCNTs | CNTSmall: |
Model: C57BL/6 mice Dose: 0, 18, 54 or 162 μg/mouse Exposure time: 24 h, 3 days and 28 days |
Intracellular flow was increased in bronchoalveolar lavage fluid Interstitial pneumonia The mRNA levels of chemokines CCLs and CXCLs were changed | [ |
| NiO NPs | 26 nm |
Model: Wistar rats Dose: 0.33 or 0.66 mg/kg Exposure time: 3 days, 1 week, 1 month, 3 months and 6 months |
The concentrations of CINC-1 and CINC-2αβ were increased The concentration of CINC-3 was decreased Alveolar infiltration by neutrophils and alveolar macrophages occurred | [ | |
| Asthma | NENPs | <100 nm |
Model: Population-based cohort study Dose: Not mentioned Exposure time: Not mentioned |
NENPs was independently associated with the incidence of childhood asthma | [ |
| TiO2 NPs | Not mentioned |
Model: HNBE cells Dose: 1, 5, or 10 μM/well (six-well plates) Exposure time: 8 and 24 h Model: BALB/c mice Dose: 200 μg/m3 1 h a day for 3 days Exposure time: 21–23 days |
Bradykinin, ATP and CGRP were increased in a dose dependent manner in HNBE cells Substance P, ATP and CGRP were significantly increased in bronchoalveolar lavage fluid | [ | |
| Pulmonary | SWCNTs | 1–4 nm |
Model: C57BL/6 mice Dose: 0,10,20 or 40 μg/mouse Exposure time: 1, 3, 7, 28, and 60 days |
Robust but acute inflammation occurred Early onset yet progressive fibrosis and granulomas occurred | [ |
| Atherosclerosis | Ni(OH)2 NPs | ~5 nm |
Model: ApoE−/− mice Dose: 0 or 79 μg Ni/m3 Exposure time: 5 h/day, 5 days/week, for either 1 week or 5 months |
Oxidative stress and inflammation occurred Atherosclerosis was intensified The transcript levels of several genes involved in atherosclerosis (CCL-2, VCAM-1 and CD68) were also increased | [ |
| Myocardial | C60 | 50–200 nm |
Model: Sprague Dawley rats Dose: 28 μg/mouse Exposure time: 24 h |
Vasoconstriction was increased Vasodilation was impaired | [ |
| Neurological | NENPs | Not mentioned |
Model: Population-based cohort study Dose: Not mentioned Exposure time: Not mentioned |
Visual performance deteriorated Cognitive performance was impaired Balance was impaired | [ |
| NENPs | Not mentioned |
Model: Population-based cohort study Dose: Not mentioned Exposure time: Not mentioned |
There was a strong association between living near a major urban road (less than 50 m) and dementia risk. | [ | |
| SiO2 NPs | 115 nm |
Model: C57BL/6 mice Dose: 8 mg/kg Exposure time: 1 and 2 months |
NPs deposition was mainly detected in the medial prefrontal cortex and hippocampus Neurodegeneration-like pathological changes, including reduced Nissl staining, increased tau phosphorylation, and neuroinflammation | [ | |
| Endocrine disturbance | Polystyrene nanoplastics | 38.92 nm |
Model: Wistar rats Dose: 1, 3, 6 or 10 mg/kg/day Exposure time: 5 weeks |
Exposure to polystyrene nano plastics was negatively correlated with serum concentrations of testosterone, luteinizing hormone and follicle stimulating hormone. DNA damage Sperm morphology and motility were changed | [ |
| Acute myeloid | NENPs | Not mentioned |
Model: Population-based cohort study Dose: Not mentioned Exposure time: Not mentioned |
NENPs were found to be linked and aggregated to blood components in AML patients, while almost absent in matched healthy controls. | [ |
Figure 5Human health hazards caused by inhaled NPs.